• 1999 final rule provisions that are stayed until December 1, 2006:

    • 21 CFR 203.3(u): “Ongoing relationship” defined to include a written agreement between manufacturer and wholesaler

    • 21 CFR 203.50: specifies the information to be included in the drug pedigree; information to be traceable back to 1st sale by manufacturer